Clinical Determinants of von Willebrand Factor Antigen, Activity, and Factor VIII Levels in Transfusion‐Dependent Beta‐Thalassemia

INTRODUCTION: Von Willebrand factor (VWF) and factor VIII (FVIII) levels are influenced by multiple physiological and disease-related factors. Patients with transfusion-dependent beta thalassemia (TDT) present a complex clinical setting characterized by chronic anaemia, iron overload, inflammation, and endothelial dysfunction, yet data on the determinants of VWF and FVIII in this population remain limited. AIM: To evaluate VWF antigen (VWF:Ag), VWF:GPIbM, and FVIII activity in patients with TDT and identify their clinical and laboratory determinants. METHODS: In this cross-sectional study, 180 patients with TDT from an outpatient thalassemia clinic in Shiraz, Iran, were enrolled. Demographic data, ABO blood group, splenectomy status, pre-transfusion haemoglobin, platelet count, and serum ferritin were recorded. VWF:Ag, VWF:GPIbM, and FVIII activity were measured using standard coagulation assays. Independent predictors were identified using multivariable linear regression. RESULTS: Median VWF:Ag, VWF:GPIbM, and FVIII activity were 121 IU/dL, 121 IU/dL, and 100 IU/dL, respectively. Non-O blood groups were associated with higher VWF:Ag, VWF:GPIbM, and FVIII activity compared with blood group O (p < 0.001). Body mass index independently predicted VWF:Ag, VWF:GPIbM, and FVIII activity. Splenectomy was associated with higher FVIII activity. Platelet count was inversely associated with VWF:GPIbM, whereas pre-transfusion haemoglobin showed an inverse association with FVIII activity. Serum ferritin was not significantly associated with VWF or FVIII levels. CONCLUSION: VWF and FVIII levels in TDT are influenced by haemoglobin, blood group, body mass index, splenectomy status, and platelet count. These modifiers may complicate the interpretation of haemostatic assays and should be considered when evaluating bleeding disorders in this population.

Authors

Institutions

Publication Details

Journal
Haemophilia
Published
2026-11-16
DOI
https://doi.org/10.1111/hae.70460
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Determinants of von Willebrand Factor Antigen, Activity, and Factor VIII Levels in Transfusion‐Dependent Beta‐Thalassemia

Amin Shahsavani, Shayan Bordbar, Asghar Bazrafshan, Maral Mokhtari et al.
1 links
Haemophilia
Hemoglobinopathies and Related Disorders
article

Clinical Determinants of von Willebrand Factor Antigen, Activity, and Factor VIII Levels in Transfusion‐Dependent Beta‐Thalassemia

Amin Shahsavani, Shayan Bordbar, Asghar Bazrafshan, Maral Mokhtari, Sezaneh Haghpanah, Mohammadreza Bordbar, Mehran Karimi, Omid Reza Zekavat
article en

Abstract

INTRODUCTION: Von Willebrand factor (VWF) and factor VIII (FVIII) levels are influenced by multiple physiological and disease-related factors. Patients with transfusion-dependent beta thalassemia (TDT) present a complex clinical setting characterized by chronic anaemia, iron overload, inflammation, and endothelial dysfunction, yet data on the determinants of VWF and FVIII in this population remain limited. AIM: To evaluate VWF antigen (VWF:Ag), VWF:GPIbM, and FVIII activity in patients with TDT and identify their clinical and laboratory determinants. METHODS: In this cross-sectional study, 180 patients with TDT from an outpatient thalassemia clinic in Shiraz, Iran, were enrolled. Demographic data, ABO blood group, splenectomy status, pre-transfusion haemoglobin, platelet count, and serum ferritin were recorded. VWF:Ag, VWF:GPIbM, and FVIII activity were measured using standard coagulation assays. Independent predictors were identified using multivariable linear regression. RESULTS: Median VWF:Ag, VWF:GPIbM, and FVIII activity were 121 IU/dL, 121 IU/dL, and 100 IU/dL, respectively. Non-O blood groups were associated with higher VWF:Ag, VWF:GPIbM, and FVIII activity compared with blood group O (p < 0.001). Body mass index independently predicted VWF:Ag, VWF:GPIbM, and FVIII activity. Splenectomy was associated with higher FVIII activity. Platelet count was inversely associated with VWF:GPIbM, whereas pre-transfusion haemoglobin showed an inverse association with FVIII activity. Serum ferritin was not significantly associated with VWF or FVIII levels. CONCLUSION: VWF and FVIII levels in TDT are influenced by haemoglobin, blood group, body mass index, splenectomy status, and platelet count. These modifiers may complicate the interpretation of haemostatic assays and should be considered when evaluating bleeding disorders in this population.

Haemophilia
Shiraz University of Medical Sciences (IR), Faghihi Hospital (IR)
Shiraz University of Medical Sciences
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon